Correct (not sure about the date, but March sounds right). I recall NP stating that FDA requested mono pediatric data for non-clinical portion of the BLA filing. Seemed a little odd to request mono data for combo BLA. But your article / theory helps clarify this a little. Hopefully my memory is not mixing info.